About
Measuring severity in functional GI disorders (FGIDs) is extremely important since it can guide diagnostic evaluation, risk assessment, and treatment decisions. However, there has been a lack of consensus regarding severity in irritable bowel syndrome (IBS) and other FGIDs. In late 2005, the Rome Foundation assembled a working group to develop guidelines for severity assessment in FGID. This committee is comprised of members with different areas of expertise but with a mutual interest in severity and/or health outcomes assessment. The committee produced a report that has been published in the The American Journal of Gastroenterology.
Publication
Severity in Irritable Bowel Syndrome: A Rome Foundation Working Team Report
Drossman, D. A., Chang, L., Bellamy, N., Gallo-Torres, H. E., Lembo, A., Mearin, F., Norton, N., Whorwell, P.
(2011). Am J Gastroenterol, 106(10), 1749-1759; quiz 1760
Abstract
Members of the Working Team
Chair
Douglas A. Drossman, MD
UNC Center for Functional GI and Motility Disorders
Chapel Hill, North Carolina, USA
Co-Chair
Lin Chang, MD
UCLA
Center for Neurobiology of Stress
Los Angeles,California, USA
Nicholas Bellamy, DSc
Centre of National Research on Disability and Rehabilitation Medicine
The University of Queensland
Brisbane, Queensland, Australia
Hugo Gallo-Torres, MD
Food and Drug Administration
Division of Gastrointestinal and Coagulation Drug Products
Bethesda, Maryland, USA
Anthony Lembo, MD
Beth Israel Deaconess Medical Center
Harvard University
Cambridge, Massachusetts, USA
Fermín Mearin, MD
Institute of Functional and Motor Digestive Disorders
Centro Médico Teknon
Barcelona, Spain
Nancy Norton
International Foundation for Functional Gastrointestinal Disorders
Milwaukee, Wisconsin, USA
Peter Whorwell, MD, FRCP
Gastroenterology Department
Wythenshawe Hospital
Manchester University, Manchester, UK